Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone … | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.
MENU

Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone …

Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone …
Peptide News from Biotech and Pharma, Raw News September 22, 2017

MENLO PARK, CA, USA I September 21, 2017 I Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is ...

Email

support@boulderpeptide.org

s2Member®
loading...